Early detection saves lives yet millions of men continue to avoid routine cancer screenings, even when symptoms appear or when they are at high risk. This gap between what men should do and what men actually do represents one of the most urgent public health challenges of our time.
In a large European study spanning 20 years and 7 countries, men who skipped prostate cancer screening had a 45% higher risk of dying from the disease compared with those who attended.
Men who did attend screenings showed a 23% lower risk of death compared to those never invited.
According to the Cancer Research UK data, in the UK about 1 in 6 men will receive a prostate cancer diagnosis in their lifetime.
In many regions, screening participation remains very low — one study found only around 3.9% of surveyed men had ever had a PSA test.
Even when screening is available and risks are known, many men hold back. Let's see why:
1. Fear & Denial
The idea of “What if it’s bad?” makes many men put off check-ups. Avoidance feels safer than confrontation.
2. Cultural Expectations
Messages like “be tough,” “handle things yourself,” “don’t show weakness” push men into silence rather than action.
3. Awareness Gaps
Awareness does not always lead to action. Even if many men have heard of prostate cancer, far fewer understand screening options or risk factors.
4. Embarrassment & Stigma
Screenings can involve topics men are uncomfortable with—owning up to it doesn’t feel like strength.
5. “I’ll handle it later” Mindset
Life gets busy. Work, family, stress. Many men delay check-ups thinking things will be fine — until they’re not.
When screening is skipped:
Diagnosis often happens at later stages, reducing treatment options and survival rates.
The burden on individuals and families increases significantly — physically, emotionally, financially.
The broader social impact grows — fewer men returning to work, families losing fathers and partners earlier than necessary.
One study highlighted this clearly: among men invited to screenings, those who didn’t attend had a 39% higher risk of prostate-cancer-specific death compared to the control group.
Most common cancer in men in 118 countries worldwide
1 in 8 men will be diagnosed in their lifetime
Screening options: PSA blood test, MRI, biopsy if needed
Highest risk: age 45+ or strong family history
Symptoms: difficulty urinating, weak flow, blood in urine/semen, pelvic pain — or no symptoms at all (which is why screening matters).
Most common cancer in young men aged 15–35
Highly treatable if caught early
Monthly self-exam recommended
Symptoms: lump, swelling, heaviness, dull pain in groin or lower belly.
Rising rapidly in younger men
Screening recommended starting age 45 (earlier with family history)
FIT stool test, colonoscopy, or sigmoidoscopy
Symptoms: bleeding, persistent constipation or diarrhea, fatigue, weight loss.
Leading cause of cancer death in men worldwide
80–90% linked to smoking history, but also seen in non-smokers
Low-dose CT scan screening recommended for high-risk groups (50–80)
Symptoms: persistent cough, coughing blood, breathlessness, chest pain.
Often diagnosed late due to vague symptoms
Up to 3 in 4 cases could be prevented by identifying and treating H. pylori infection
High prevalence in Eastern Europe, Asia, and South America
Symptoms: indigestion, heartburn, nausea, early fullness, weight loss.
Silent and aggressive, often found late
New research is developing AI blood tests that may detect it earlier
Higher risk in smokers, diabetics, and those with family history
Symptoms: jaundice, back pain, unexplained weight loss, digestive issues.
Ask a man you know: “When was your last health check-up?” That simple question can spark awareness.
PSA test for prostate cancer (especially men 45+ or with family history)
Testicular self-exams (for younger men)
Colorectal screening (starting age 45 in many guidelines)
Lung-cancer screening for high-risk individuals (smokers/former smokers)
Strength isn’t staying silent. Strength is talking, asking questions, showing up for yourself and those who care about you.
Share this article. Post it. Forward it to a father, brother, friend, or colleague. Awareness is contagious.
Your story has the power to change someone’s tomorrow. If you’ve faced cancer — or are still facing it — send your story to: tcw@tutticancerwarriors.org Your voice could be the reason someone else feels less alone.
Follow our journey and help us spread awareness
💜 Instagram: @tutticancerwarriors
💜 X (Twitter): @NGOTCW
💜 TikTok: @tutticancerwarriors
💜 Website: tutticancerwarriors.org
Our new crossword is here! This week’s puzzle is based on last week’s edition. Test what you’ve learned, discover a few surprising facts, and keep awareness fun and interactive.
November is not only Movember. It’s also a month dedicated to raising awareness for several cancers that strongly affect both men and women:
Stomach (Gastric) Cancer Awareness Month
Pancreatic Cancer Awareness Month
Lung Cancer Awareness Month
Carcinoid / Neuroendocrine Tumor (NET) Awareness Day — November 10
National Family Caregivers Month
Men’s Mental Health Awareness Month
No-Shave November (supporting cancer education & research)
Disclaimer: The information provided here is for awareness purposes only and is not intended as medical advice. Please consult with a healthcare professional for medical concerns.
American Cancer Society. Key Statistics for Prostate Cancer.
Prostate cancer is the most commonly diagnosed cancer in men in 118 countries; lifetime risk approx. 1 in 8 men.
https://www.cancer.org/cancer/types/prostate-cancer/about/key-statistics.htmlAmerican Cancer Society Research News.
Prostate Cancer Is Number 1 for 118 Countries Worldwide.
https://www.cancer.org/research/acs-research-news/prostate-cancer-is-number-1-for-118-countries-worldwide.htmlSciTechDaily. Men Who Skip Prostate Screenings Face a 45% Higher Risk of Death.
Study findings linking screening avoidance with sharply higher mortality risk.
https://scitechdaily.com/men-who-skip-prostate-screenings-face-a-45-higher-risk-of-deathHealthline / Medical Summary of ERSPC follow-up study.
Avoiding Prostate Screenings Raises Death Risk.
https://www.healthline.com/health-news/avoiding-prostate-screenings-raises-death-riskProstate Cancer UK / Cancer Research UK.
About Prostate Cancer: Risk & Symptoms.
Lifetime risk approx. 1 in 8 men in the UK.
https://prostatecanceruk.org/prostate-information-and-support/risk-and-symptoms/about-prostate-cancerUrology Times.
Avoidance of Prostate Cancer Screening Linked to Increased Risk of Prostate-Cancer-Specific Mortality.
Summarizing ERSPC 23-year follow-up findings.
https://www.urologytimes.com/view/avoidance-of-prostate-cancer-screening-linked-to-increased-risk-of-pcsm